Instituto Nacional de Pediatria

Mexico City 4530

0 studies enrolling now · 7 studies all time

What they study most

Corona Virus Infection, Covid19, Dengue Fever, Duchenne Muscular Dystrophy, Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Hereditary Angioedema (HAE), Hunter Syndrome, Mucopolysaccharidosis (MPS), Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL), Philadelphia Chromosome-Like ALL (Ph-like ALL)

Studies at this site

• Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose — Completed
• A Study of Baricitinib (LY3009104) in Children With COVID-19 — Stopped early
• A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia — Stopped early
• Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) — Completed
• Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B — Stopped early
• Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema — Completed
• Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II) — Completed